Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news

    Tag: pharma news

    You Searched For "pharma news"
    Sun Pharma former RnD head murders family of three, then commits suicide

    Sun Pharma former RnD head murders family of three, then commits suicide

    Farhat Nasim2 July 2019 5:07 PM IST
    Gurugram: In a spine chilling incident, former head of Research & Development (R&D) at Sun Pharmaceuticals Ltd. (Sun Pharma) along with his...
    Novartis introduces 26 week gender-neutral parental leave for birth, adoption, surrogacy

    Novartis introduces 26 week gender-neutral parental leave for birth, adoption, surrogacy

    Farhat Nasim2 July 2019 12:55 PM IST
    The new parental leave policy is effective July 1, 2019 and applies to birthing and non-birthing parents in the case of birth, adoption and surrogacy,...
    Alembic Pharma gets USFDA nod for generic version of Uloric tablets

    Alembic Pharma gets USFDA nod for generic version of Uloric tablets

    Farhat Nasim2 July 2019 11:49 AM IST
    The approved product, Febuxostat tablet is therapeutically equivalent to the reference listed drug Uloric tablets of Takeda Pharmaceuticals USA, Inc....
    Alembic Pharma gets USFDA nod for Clonazepam orally disintegrating tablets

    Alembic Pharma gets USFDA nod for Clonazepam orally disintegrating tablets

    Farhat Nasim1 July 2019 12:25 PM IST
    The approval from the United States Food and Drug Administration (USFDA) is for the company's abbreviated new drug application (ANDA) for Clonazepam...
    Sandoz, Kit Check collaborate to track, automate restocking of products in hospitals

    Sandoz, Kit Check collaborate to track, automate restocking of products in hospitals

    Farhat Nasim30 Jun 2019 9:12 AM IST
    By collaborating with Kit Check, Sandoz will be able to better understand how its medicines are used in hospitals, optimize the supply chain by...
    Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL

    Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL

    Farhat Nasim29 Jun 2019 11:56 AM IST
    The court's order came on a plea by Glaxo Group Ltd which sought to restrain AFDIL from advertising, marketing or in any manner doing business under...
    Alembic Pharma clears USFDA inspection at oncology unit in Panelav

    Alembic Pharma clears USFDA inspection at oncology unit in Panelav

    Farhat Nasim29 Jun 2019 10:02 AM IST
    This was a first scheduled inspection and Alembic Pharma passed the inspection without any Form 483 Observation.New Delhi: Alembic Pharmaceuticals...
    Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

    Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

    Medical Dialogues Bureau28 Jun 2019 12:30 PM IST
    The initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...
    Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets

    Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets

    Farhat Nasim28 Jun 2019 11:10 AM IST
    The approval by the US Food and Drug Administration (USFDA) is for a generic version of Mirabegron ER tablets of strengths 25 mg and 50 mg, Lupin said...
    Bharat Biotech, Hilleman Labs collaborate to develop oral cholera vaccine HILLCHOL

    Bharat Biotech, Hilleman Labs collaborate to develop oral cholera vaccine HILLCHOL

    Medical Dialogues Bureau26 Jun 2019 4:42 PM IST
    New Delhi: Hyderabad-based vaccine maker, Bharat Biotech and Hilleman Laboratories today entered into a collaboration for further development,...
    Dr Reddys launches generic version of Tobi in US market

    Dr Reddys launches generic version of Tobi in US market

    Farhat Nasim26 Jun 2019 3:07 PM IST
    The product is a therapeutic equivalent generic version of TOBI (tobramycin) Inhalation Solution, approved by the U.S. Food and Drug Administration...
    Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene

    Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene

    Medical Dialogues Bureau26 Jun 2019 9:00 AM IST
    Bristol-Myers announced its plans to buy Celgene in a cash-and-stock deal in early January to bring together the companies that specialize in oncology...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok